Immunotherapy Response Assessment in Neuro-Oncology Criteria

**Semantic type:** Intellectual Product

**Definition:** Response assessment criteria for the evaluation of patients undergoing immunotherapy for the treatment of malignant glioma. These recommendations integrate guidance for the determination and confirmation of tumor progression based on the response assessment in neuro-oncology (RANO) working group and the immune-related response criteria (irRC).

**Synonyms:** - Immunotherapy Response Assessment for Neuro-Oncology - iRANO - iRANO Criteria